- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Federal Health IT Market Poised for Growth
Investments in health IT systems and services by federal government agencies will increase from $4.5 billion in 2011 to $6.5 billion in 2016 at a compound annual growth rate of 7.5 percent, according to a new GovWin report from research firm Deltek.
“Federal Health Information Technology Market, 2011-2016” explores the federal health IT market environment and future trends and their anticipated impact on vendors, VARS, systems integrators, and federal contractors over the next 5 years.
The federal IT market is seeing unprecedented change that will transform the market over the next decade, moving from a slow but stable market to one that will change continuously in many ways, the report notes. The eventual future of federal IT is one of continuous services that can be accessed by an increasing variety of devices connected via clouds.
Read more at: http://healthcareitnews.com/news/federal-health-it-market-poised-growth
Source: Healthcare IT News
Personalized Care Key as Tirzepatide Use Expands Rapidly
April 15th 2025Using commercial insurance claims data and the US launch of tirzepatide as their dividing point, John Ostrominski, MD, Harvard Medical School, and his team studied trends in the use of both glucose-lowering and weight-lowering medications, comparing outcomes between adults with and without type 2 diabetes.
Listen
FDA Greenlights Dupilumab for Chronic Spontaneous Urticaria, Marking First Approval in a Decade
April 18th 2025Marking the first approval in over a decade for this challenging condition, the FDA has approved dupilumab (Dupixent) to treat chronic spontaneous urticaria in patients 12 years and older whose hives and itching remain uncontrolled by antihistamines.
Read More
